Live Breaking News & Updates on Ardiovascular events

Stay informed with the latest breaking news from Ardiovascular events on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Ardiovascular events and stay connected to the pulse of your community

Daily marijuana smokers face higher risk of heart attack, stroke, says American Heart Association study

A new study published in the Journal of the American Heart Association found that daily weed smoking could cause complications in heart health. Study authors and heart health experts discuss.

Colorado , United-states , Massachusetts , American , Americans , Salomeh-keyhani , Robert-page , University-of-colorado-school-medicine , Journal-of-the-american-heart-association , National-cannabis-industry-association , University-of-california-san-francisco , American-heart-association

FDA warns against counterfeit Ozempic

(KRON) – The U.S. Food and Drug Administration and Novo Nordisk are investigating counterfeit Ozempic (semaglutide). Ozempic is an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Ozempic also is used to reduce the risk of major adverse cardiovascular events. The manufacturer of Ozempic Novo Nordisk and […]

Ozempic-novo-nordisk , Drug-administration , Novo-nordisk , Ood-and-drug-administration , Zempic , Ype-2-diabetes-mellitus , Ardiovascular-events ,

INPEFA® (sotagliflozin) Use Associated With Early Clinical Benefit in Heart Failure and Atherosclerotic Events in Analysis of Clinical Data

Oral presentation delivered at the American Heart Association (AHA) Scientific Sessions 2023 Analysis of clinical data shows statistically significant risk reductions in heart failure and separately in MACE related outcomes as early as approximately three months in patients at high risk for cardiovascular events INPEFA® (sotagliflozin) recently approved by FDA for treatment of heart failure THE WOODLANDS, Texas, Nov. 12, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today

Pennsylvania , United-states , Philadelphia , Boston , Massachusetts , Texas , American , Rahul-aggarwal , Craig-granowitz , Exchange-commission , Lexicon-pharmaceuticals , Lexicon-pharmaceuticals-inc

Novo Nordisk to acquire ocedurenone for uncontrolled hypertension from KBP Biosciences

Bagsværd, Denmark and Singapore, 16 October 2023 – Novo Nordisk A/S and KBP Biosciences PTE., Ltd. today announced that Novo Nordisk has agreed to acquire ocedurenone for uncontrolled hypertension with potential application in cardiovascular and kidney disease from KBP Biosciences for up to 1.3 billion US dollars. Ocedurenone is an orally administered, small molecule, non-steroidal mineralocorticoid receptor antagonist (nsMRA) that is currently being examined in the phase 3 trial CLARION-CKD in

United-states , Singapore , Denmark , Fred-yang , Martin-holst-lange , Novo-nordisk , Zhenhua-huang , Camilla-sylvest , Goodwin-procter , Covington-burling , Linkedin , Youtube

Anti-obesity drugs can shrink more than patients

Starry-eyed venture capitalists love to talk about how promising startups might capture a chunk of a giant total addressable market (TAM). New anti-obesity drugs have the potential to transform public health, while obliterating demand for products and services from the medical, food and fitness industries. Drugs developed by Novo Nordisk and Eli Lilly appear to be the first truly effective diet treatments.

United-states , London , City-of , United-kingdom , Canada , Americans , Canadian , Michael-farrell , Oliver-taslic , Kraft-heinz , Zimmer-biomet , Robert-cyran

Amarin Provides Pricing & Reimbursement Updates for VAZKEPA (icosapent ethyl) in The Netherlands and Italy

– Dutch Ministry of Health Approves VAZKEPA® (icosapent ethyl) for National Reimbursement to Reduce the Risk of Cardiovascular Events in Patients with Established Cardiovascular Disease – – Italy’s AIFA Pricing & Reimbursement Committee (CPR) Issues Negative Decision on VAZKEPA; Follows Positive Scientific Assessment by the Italian Scientific Technical Committee (CTS) – DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced p

Netherlands , Italy , United-states , New-jersey , Dublin , Ireland , Switzerland , Italian , The-netherlands , Dutch , Mark-marmur , Patrick-holt

Obesity Drug Wegovy Found to Prevent Heart Attacks, Strokes in Major Trial

Wegovy, the popular obesity treatment, also seems to offer heart health benefits. On Tuesday, Novo Nordisk reported the results of a comprehensive clinical trial evaluating the drug’s efficacy in preventing heart attacks and strokes in overweight or obese individuals. According to the company, Wegovy cut the risk of major cardiovascular events by 20% for up to five years when compared to a placebo.

Novo-nordisk-ozempic , Martin-holst-lange , Novo-nordisk , Instagram , Drug-administration , Facebook , Development-at-novo-nordisk , Twitter , Semaglutide-effects , Heart-disease , Eight-loss , Ardiovascular-events

Wegovy shown to cut risk of stroke and heart attacks, company says

The popular obesity drug Wegovy cuts the risk of cardiovascular events, such as heart attack and stroke, by 20%, drugmaker Novo Nordisk said Tuesday.

Centers-for-disease , Novo-nordisk , Drug-administration , Disease-control , Eight-reduction , Ardiovascular-benefits , Hauna-levy , Eart-attack , Ardiovascular-events ,

GLP-1 Agonists can reduce risk of mortality, liver failure in patients with type 2 diabetes and cirrhosis

Taiwan: A recent population-based cohort study published in Clinical Gastroenterology and Hepatology has revealed multiple benefits of glucagon-like peptide-1 receptor agonist (GLP-1 RA) in patients...

Taiwan , Taipei , T-ai-pei , Chiao-tung-university , Xinzhu-xian , Cheng-chung-wei , Clin-gastroenterol-hepatol , National-yang-ming-chiao-tung-university , National-health-insurance-research-database-of-taiwan , Chii-min-hwu , National-health-insurance-research-database , Agonist-use

The Potential Heart Health Benefits of Alcohol Might Be Thanks to Your Brain, a New Study Suggests

Not to be a buzzkill, but the researchers still aren't giving you an Rx to drink daily—find out why.

United-states , Boston , Massachusetts , Americans , Ahmed-tawakol , Brigham-biobank , Heart-health-study-found , Cardiovascular-imaging-research-center-at-massachusetts , Journal-of-the-american-college-cardiology , Harvard-medical-school , Dietitian-jessica-ball , American-college